Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
65,515,285
-
Share change
-
-4,222,480
-
Total reported value
-
$4,880,560,789
-
Put/Call ratio
-
133%
-
Price per share
-
$74.53
-
Number of holders
-
342
-
Value change
-
-$732,202,425
-
Number of buys
-
179
-
Number of sells
-
241
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2021
As of 31 Mar 2021 Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) had 342 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 65,515,285 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, BlackRock Inc., FMR LLC, SANDS CAPITAL MANAGEMENT, LLC, Avoro Capital Advisors LLC, STATE STREET CORP, ARK Investment Management LLC, and Bank of New York Mellon Corp.
This table shows 346 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.